RSV disease severity compared to COVID-19 and influenza in hospitalized older adults

This was an observational report from the IVY Network across 20 U.S. states. It described disease severity among hospitalized adults aged 60 years or older with respiratory syncytial virus (RSV) compared to hospitalizations for COVID-19 or influenza. The report did not specify a primary outcome, secondary outcomes, or a follow-up period. Sample size was not reported.

No main results, including comparative severity measures or clinical outcomes, were provided in the available data. The report lacked specific numerical findings regarding disease severity differences between RSV, COVID-19, and influenza in this hospitalized older adult population.

Safety and tolerability data, including adverse events and discontinuations, were not reported. Key limitations of the evidence were not specified in the input. Funding sources and potential conflicts of interest were also not reported.

Given the absence of reported results and the descriptive, observational nature of this report, its direct practice relevance cannot be assessed. Clinicians should note this as an incomplete data summary rather than evidence supporting clinical comparisons.